title: Erlotinib in metastatic bronchopulmonary mucoepidermoid carcinoma.
authors.affiliation: Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China. kirsty.lee@gmail.com
authors.forename: Kirsty W C
authors.initials: KW
authors.lastname: Lee
authors.forename: Amy B W
authors.initials: AB
authors.lastname: Chan
authors.forename: Anthony W I
authors.initials: AW
authors.lastname: Lo
authors.forename: Kwok Chi
authors.initials: KC
authors.lastname: Lam
mesh_terms: D000328:Adult; D018277:Carcinoma, Mucoepidermoid / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008297:Male; D008479:Mediastinal Neoplasms / Q000473:pathology* / Q000601:surgery; D010997:Pleural Neoplasms / Q000188:drug therapy / Q000556:secondary; D047428:Protein Kinase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use*; D013160:Splenic Neoplasms / Q000188:drug therapy / Q000556:secondary
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride